UPLOAD Filing
Ensysce Biosciences, Inc.
Date: April 21, 2025 · CIK: 0001716947 · Accession: 0000000000-25-004200
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286580
Letter
Re: Ensysce Biosciences, Inc. Registration Statement on Form S-3 Filed April 16, 2025 File No. 333-286580 Dear Lynn Kirkpatrick:
April 21, 2025
Lynn Kirkpatrick Chief Executive Officer Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue, Suite 201 La Jolla, CA 92037
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Gregory J. Rubis, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 21, 2025 Lynn Kirkpatrick Chief Executive Officer Ensysce Biosciences, Inc. 7946 Ivanhoe Avenue, Suite 201 La Jolla, CA 92037 Re: Ensysce Biosciences, Inc. Registration Statement on Form S-3 Filed April 16, 2025 File No. 333-286580 Dear Lynn Kirkpatrick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Gregory J. Rubis, Esq. </TEXT> </DOCUMENT>